Excelsior Biopharma Inc.
TWO: 6496.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Joseph Chen
- Headquarters
- Taipei, Canada
- IPO year
- 2014
- Market cap
- NT$1.1B
- Website
- https://www.excelsiorgroup.com.tw
Loading 6496…
Loading profile data…Frequently asked questions about 6496
What does Excelsior Biopharma Inc. (6496.TWO) do?
Excelsior Biopharma Inc. develops and sells pharmaceutical products in Taiwan, China, and internationally. It offers prescription drugs, over-the-counter drugs, medical devices, healthcare food products, medical supplies, and other products. The company provides its products for the therapeutic areas, such as pediatrics, gastroenterology, neurol...
Where does 6496.TWO trade?
Excelsior Biopharma Inc. (6496.TWO) trades on the Taipei Exchange.
What sector is 6496.TWO in?
Excelsior Biopharma Inc. (6496.TWO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Excelsior Biopharma Inc.?
Joseph Chen is the chief executive officer of Excelsior Biopharma Inc. (6496.TWO).
Where is Excelsior Biopharma Inc. headquartered?
Excelsior Biopharma Inc. is headquartered in Canada.
Does 6496.TWO pay a dividend?
Excelsior Biopharma Inc. (6496.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 6496.TWO go public?
Excelsior Biopharma Inc. (6496.TWO) completed its initial public offering in 2014.